Based on the Biopharmaceutical Third Party Logistics (3PL) market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Biopharmaceutical Third Party Logistics (3PL) market covered in Chapter 5:
DB Schenker
AmerisourceBergen Corporation
Kuehne and Nagel
Kerry logistics Network Limited
United Parcel Service of America, Inc
Agility
DHL International GmbH
SF Express
In Chapter 6, on the basis of types, the Biopharmaceutical Third Party Logistics (3PL) market from 2015 to 2025 is primarily split into:
Cold Chain
Non-cold Chain
In Chapter 7, on the basis of applications, the Biopharmaceutical Third Party Logistics (3PL) market from 2015 to 2025 covers:
Transportation
Warehousing and Storage
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Biopharmaceutical Third Party Logistics (3PL) Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis
2. Market Dynamics
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact
3 Associated Industry Assessment
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain
4 Market Competitive Landscape
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans
5 Analysis of Leading Companies
5.1 DB Schenker
5.1.1 DB Schenker Company Profile
5.1.2 DB Schenker Business Overview
5.1.3 DB Schenker Biopharmaceutical Third Party Logistics (3PL) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 DB Schenker Biopharmaceutical Third Party Logistics (3PL) Products Introduction
5.2 AmerisourceBergen Corporation
5.2.1 AmerisourceBergen Corporation Company Profile
5.2.2 AmerisourceBergen Corporation Business Overview
5.2.3 AmerisourceBergen Corporation Biopharmaceutical Third Party Logistics (3PL) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 AmerisourceBergen Corporation Biopharmaceutical Third Party Logistics (3PL) Products Introduction
5.3 Kuehne and Nagel
5.3.1 Kuehne and Nagel Company Profile
5.3.2 Kuehne and Nagel Business Overview
5.3.3 Kuehne and Nagel Biopharmaceutical Third Party Logistics (3PL) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Kuehne and Nagel Biopharmaceutical Third Party Logistics (3PL) Products Introduction
5.4 Kerry logistics Network Limited
5.4.1 Kerry logistics Network Limited Company Profile
5.4.2 Kerry logistics Network Limited Business Overview
5.4.3 Kerry logistics Network Limited Biopharmaceutical Third Party Logistics (3PL) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Kerry logistics Network Limited Biopharmaceutical Third Party Logistics (3PL) Products Introduction
5.5 United Parcel Service of America, Inc
5.5.1 United Parcel Service of America, Inc Company Profile
5.5.2 United Parcel Service of America, Inc Business Overview
5.5.3 United Parcel Service of America, Inc Biopharmaceutical Third Party Logistics (3PL) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 United Parcel Service of America, Inc Biopharmaceutical Third Party Logistics (3PL) Products Introduction
5.6 Agility
5.6.1 Agility Company Profile
5.6.2 Agility Business Overview
5.6.3 Agility Biopharmaceutical Third Party Logistics (3PL) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 Agility Biopharmaceutical Third Party Logistics (3PL) Products Introduction
5.7 DHL International GmbH
5.7.1 DHL International GmbH Company Profile
5.7.2 DHL International GmbH Business Overview
5.7.3 DHL International GmbH Biopharmaceutical Third Party Logistics (3PL) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 DHL International GmbH Biopharmaceutical Third Party Logistics (3PL) Products Introduction
5.8 SF Express
5.8.1 SF Express Company Profile
5.8.2 SF Express Business Overview
5.8.3 SF Express Biopharmaceutical Third Party Logistics (3PL) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 SF Express Biopharmaceutical Third Party Logistics (3PL) Products Introduction
6 Market Analysis and Forecast, By Product Types
6.1 Global Biopharmaceutical Third Party Logistics (3PL) Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Biopharmaceutical Third Party Logistics (3PL) Sales and Market Share by Types (2015-2020)
6.1.2 Global Biopharmaceutical Third Party Logistics (3PL) Revenue and Market Share by Types (2015-2020)
6.1.3 Global Biopharmaceutical Third Party Logistics (3PL) Price by Types (2015-2020)
6.2 Global Biopharmaceutical Third Party Logistics (3PL) Market Forecast by Types (2020-2025)
6.2.1 Global Biopharmaceutical Third Party Logistics (3PL) Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Biopharmaceutical Third Party Logistics (3PL) Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Biopharmaceutical Third Party Logistics (3PL) Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Biopharmaceutical Third Party Logistics (3PL) Sales, Price and Growth Rate of Cold Chain
6.3.2 Global Biopharmaceutical Third Party Logistics (3PL) Sales, Price and Growth Rate of Non-cold Chain
6.4 Global Biopharmaceutical Third Party Logistics (3PL) Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Cold Chain Market Revenue and Sales Forecast (2020-2025)
6.4.2 Non-cold Chain Market Revenue and Sales Forecast (2020-2025)
7 Market Analysis and Forecast, By Applications
7.1 Global Biopharmaceutical Third Party Logistics (3PL) Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Biopharmaceutical Third Party Logistics (3PL) Sales and Market Share by Applications (2015-2020)
7.1.2 Global Biopharmaceutical Third Party Logistics (3PL) Revenue and Market Share by Applications (2015-2020)
7.2 Global Biopharmaceutical Third Party Logistics (3PL) Market Forecast by Applications (2020-2025)
7.2.1 Global Biopharmaceutical Third Party Logistics (3PL) Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Biopharmaceutical Third Party Logistics (3PL) Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Biopharmaceutical Third Party Logistics (3PL) Revenue, Sales and Growth Rate of Transportation (2015-2020)
7.3.2 Global Biopharmaceutical Third Party Logistics (3PL) Revenue, Sales and Growth Rate of Warehousing and Storage (2015-2020)
7.3.3 Global Biopharmaceutical Third Party Logistics (3PL) Revenue, Sales and Growth Rate of Others (2015-2020)
7.4 Global Biopharmaceutical Third Party Logistics (3PL) Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Transportation Market Revenue and Sales Forecast (2020-2025)
7.4.2 Warehousing and Storage Market Revenue and Sales Forecast (2020-2025)
7.4.3 Others Market Revenue and Sales Forecast (2020-2025)
8 Market Analysis and Forecast, By Regions
8.1 Global Biopharmaceutical Third Party Logistics (3PL) Sales by Regions (2015-2020)
8.2 Global Biopharmaceutical Third Party Logistics (3PL) Market Revenue by Regions (2015-2020)
8.3 Global Biopharmaceutical Third Party Logistics (3PL) Market Forecast by Regions (2020-2025)
9 North America Biopharmaceutical Third Party Logistics (3PL) Market Analysis
9.1 Market Overview and Prospect Analysis
9.2 North America Biopharmaceutical Third Party Logistics (3PL) Market Sales and Growth Rate (2015-2020)
9.3 North America Biopharmaceutical Third Party Logistics (3PL) Market Revenue and Growth Rate (2015-2020)
9.4 North America Biopharmaceutical Third Party Logistics (3PL) Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Biopharmaceutical Third Party Logistics (3PL) Market Analysis by Country
9.6.1 U.S. Biopharmaceutical Third Party Logistics (3PL) Sales and Growth Rate
9.6.2 Canada Biopharmaceutical Third Party Logistics (3PL) Sales and Growth Rate
9.6.3 Mexico Biopharmaceutical Third Party Logistics (3PL) Sales and Growth Rate
10 Europe Biopharmaceutical Third Party Logistics (3PL) Market Analysis
10.1 Market Overview and Prospect Analysis
10.2 Europe Biopharmaceutical Third Party Logistics (3PL) Market Sales and Growth Rate (2015-2020)
10.3 Europe Biopharmaceutical Third Party Logistics (3PL) Market Revenue and Growth Rate (2015-2020)
10.4 Europe Biopharmaceutical Third Party Logistics (3PL) Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Biopharmaceutical Third Party Logistics (3PL) Market Analysis by Country
10.6.1 Germany Biopharmaceutical Third Party Logistics (3PL) Sales and Growth Rate
10.6.2 United Kingdom Biopharmaceutical Third Party Logistics (3PL) Sales and Growth Rate
10.6.3 France Biopharmaceutical Third Party Logistics (3PL) Sales and Growth Rate
10.6.4 Italy Biopharmaceutical Third Party Logistics (3PL) Sales and Growth Rate
10.6.5 Spain Biopharmaceutical Third Party Logistics (3PL) Sales and Growth Rate
10.6.6 Russia Biopharmaceutical Third Party Logistics (3PL) Sales and Growth Rate
11 Asia-Pacific Biopharmaceutical Third Party Logistics (3PL) Market Analysis
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Biopharmaceutical Third Party Logistics (3PL) Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Biopharmaceutical Third Party Logistics (3PL) Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Biopharmaceutical Third Party Logistics (3PL) Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Biopharmaceutical Third Party Logistics (3PL) Market Analysis by Country
11.6.1 China Biopharmaceutical Third Party Logistics (3PL) Sales and Growth Rate
11.6.2 Japan Biopharmaceutical Third Party Logistics (3PL) Sales and Growth Rate
11.6.3 South Korea Biopharmaceutical Third Party Logistics (3PL) Sales and Growth Rate
11.6.4 Australia Biopharmaceutical Third Party Logistics (3PL) Sales and Growth Rate
11.6.5 India Biopharmaceutical Third Party Logistics (3PL) Sales and Growth Rate
12 South America Biopharmaceutical Third Party Logistics (3PL) Market Analysis
12.1 Market Overview and Prospect Analysis
12.2 South America Biopharmaceutical Third Party Logistics (3PL) Market Sales and Growth Rate (2015-2020)
12.3 South America Biopharmaceutical Third Party Logistics (3PL) Market Revenue and Growth Rate (2015-2020)
12.4 South America Biopharmaceutical Third Party Logistics (3PL) Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Biopharmaceutical Third Party Logistics (3PL) Market Analysis by Country
12.6.1 Brazil Biopharmaceutical Third Party Logistics (3PL) Sales and Growth Rate
12.6.2 Argentina Biopharmaceutical Third Party Logistics (3PL) Sales and Growth Rate
12.6.3 Columbia Biopharmaceutical Third Party Logistics (3PL) Sales and Growth Rate
13 Middle East and Africa Biopharmaceutical Third Party Logistics (3PL) Market Analysis
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Biopharmaceutical Third Party Logistics (3PL) Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Biopharmaceutical Third Party Logistics (3PL) Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Biopharmaceutical Third Party Logistics (3PL) Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Biopharmaceutical Third Party Logistics (3PL) Market Analysis by Country
13.6.1 UAE Biopharmaceutical Third Party Logistics (3PL) Sales and Growth Rate
13.6.2 Egypt Biopharmaceutical Third Party Logistics (3PL) Sales and Growth Rate
13.6.3 South Africa Biopharmaceutical Third Party Logistics (3PL) Sales and Growth Rate
14 Conclusions and Recommendations
14.1 Key Market Findings and Prospects
14.2 Advice for Investors
15 Appendix
15.1 Methodology
15.2 Research Data Source
List of Tables and Figures
Figure Product Picture
Figure Global Biopharmaceutical Third Party Logistics (3PL) Market Size and Growth Rate 2015-2025
Table Biopharmaceutical Third Party Logistics (3PL) Key Market Segments
Figure Global Biopharmaceutical Third Party Logistics (3PL) Market Revenue ($) Segment by Type from 2015-2020
Figure Global Biopharmaceutical Third Party Logistics (3PL) Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of Biopharmaceutical Third Party Logistics (3PL)
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table DB Schenker Company Profile
Table DB Schenker Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure DB Schenker Production and Growth Rate
Figure DB Schenker Market Revenue ($) Market Share 2015-2020
Table AmerisourceBergen Corporation Company Profile
Table AmerisourceBergen Corporation Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure AmerisourceBergen Corporation Production and Growth Rate
Summary: Get latest Market Research Reports on Biopharmaceutical Third Party Logistics (3PL). Industry analysis & Market Report on Biopharmaceutical Third Party Logistics (3PL) is a syndicated market report, published as Global Biopharmaceutical Third Party Logistics (3PL) Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery. It is complete Research Study and Industry Analysis of Biopharmaceutical Third Party Logistics (3PL) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.